- Country: Philippines
- Summary: Dugang Hatud Serbisyo.552
- PHT Ref No: 130338989
- Deadline: 25 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PHP 87764.65
- Notice Type: Tender
- Document Ref. No.: 20252133
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for Dugang Hatud Serbisyo.552
Procurement Mode : Negotiated Procurement - Small Value Procurement (Sec. 53.9)
Classification : Goods
Category : Medical Supplies and Laboratory Instrument
Contract Duration : 14 Day/s
Budget for the Contract : PHP 87,764.65
Area of Delivery : Bukidnon
Description : 210 bot Ambroxol 6mg/ml drops in 15ml
20 bot phenylephrine HICL + Chlorphenamine Maleate 2.5mg/0.5mg/ml Drops in 10ml
20 bot Simeticone 40mg/ml/Drop in 10ml
20 bot Ambroxol 15mg/5ml/syrup in 60ml
1 box Betahistamine 8mg tab in 100's
Trade Agreement : Implementing Rules and Regulations - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDugang Hatud Serbisyo.552 - Philippines Tender
The CITY OF MALAYBALAY, BUKIDNON, a Government sector organization in Philippines, has announced a new tender for Dugang Hatud Serbisyo.552. This tender is published on PhilippinesTenders under PHT Ref No: 130338989 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-25.
The estimated tender value is PHP 87764.65, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
